Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

SERUM FERRITIN CONCENTRATION IN SOLID TUMOR PATIENTS (CROSBI ID 208605)

Prilog u časopisu | ostalo

Skoko, Marija ; Mihić Lasan, Irena ; Culej, Jelena ; Krajačić Karas, Gorana ; Vučemilo, Tiha ; Šturm, Deana SERUM FERRITIN CONCENTRATION IN SOLID TUMOR PATIENTS // Libri oncologici : Croatian journal of oncology, Vol 40 (2012), 1-5

Podaci o odgovornosti

Skoko, Marija ; Mihić Lasan, Irena ; Culej, Jelena ; Krajačić Karas, Gorana ; Vučemilo, Tiha ; Šturm, Deana

engleski

SERUM FERRITIN CONCENTRATION IN SOLID TUMOR PATIENTS

Ferritin is a positive acute phase reactant. It is produced and secreted by various cells such as hepatocytes, macrophages and cancer cells. This was a retrospective study which included 46 patients with solid tumors who were tested for ferritin level in plasma. The measured value of the ferritin concentration in plasma of patients was in the range from 5.98 to 850.78 ug/L, and the average measured value was 174, 62ug/L. For the control group, we also included 46 subjects. The measured value of ferritin in the control group was in the range from 5.94 to 351.54ug/L, and the average measured value was 63.17ug/L. There is a statistically significant difference between the two groups. Our data shows that the highest level of ferritin was measured in patient with breast cancer. By many studies done until now it is shown that iron metabolism is dysregulated in cancer, and that changes occur in both intracellular and extracellular ferritin.

ferritin ; cancer ; H-subunit ; iron

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

Vol 40

2012.

1-5

objavljeno

0300-8142

Povezanost rada

nije evidentirano

Indeksiranost